Oral cimetidine in severe duodenal ulceration. A double-blind controlled trial.

PubWeight™: 3.95‹?› | Rank: Top 1%

🔗 View Article (PMID 63673)

Published in Lancet on January 01, 1977

Authors

G R Gray, I S Smith, I McKenzie, G P Crean, G Gillespie

Articles citing this

Cimetidine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative study. Postgrad Med J (1980) 3.02

Cimetidine in patients with gastric ulcer: a multicentre controlled trial. Br Med J (1977) 2.08

Controlled trial of maintenance cimetidine treatment in healed duodenal ulcer: short and long-term effects. Gut (1979) 1.90

Double-blind comparison of cimetidine and placebo in the maintenance of healing of chronic duodenal ulceration. Gut (1979) 1.43

Cimetidine: prophylaxis against upper gastrointestinal haemorrhage after renal transplantation. Br Med J (1978) 1.39

Bedtime cimetidine maintenance treatment: optimum dose and effect on subsequent natural history of duodenal ulcer. Gut (1982) 1.33

Comparison of two doses of cimetidine and placebo in the treatment of duodenal ulcer: a multicentre trial. Gut (1979) 1.21

Controlled therapeutic trial to determine the optimum dose of antacids in duodenal ulcer. Gut (1984) 1.06

Ranitidine compared with cimetidine in the short-term healing of duodenal ulcer. Postgrad Med J (1983) 0.97

Cimetidine for ulcers recurring after gastric surgery. Br Med J (1978) 0.86

Therapeutic effect of cimetidine in patients undergoing haemodialysis. Br Med J (1979) 0.85

Cimetidine and peptic ulceration in a Meckel's diverticulum. Arch Dis Child (1980) 0.79

Cimetidine in the management of the Zollinger-Ellison syndrome. Postgrad Med J (1977) 0.78

Review of general surgery 1977. Postgrad Med J (1978) 0.76

Cimetidine and gastric carcinoma. Br Med J (1977) 0.76

Cimetidine for ever (and ever and ever...)? Br Med J (1978) 0.75

Deduction of duodenal ulcer recurrence by healing with cimetidine plus sulpiride. Gut (1986) 0.75

Current medical management of duodenal ulcer disease. Can Med Assoc J (1977) 0.75

A review of the Zollinger-Ellison syndrome--with particular reference to a patient treated with cimetidine. Postgrad Med J (1979) 0.75

Medical staff conference: cimetidine. West J Med (1979) 0.75

Articles by these authors

Effect of season and temperature on mortality in amphibians due to chytridiomycosis. Aust Vet J (2004) 3.16

Separation of suppressor and killer T cells by surgace phenotype. Nature (1976) 3.03

Prophylactic oral antimicrobial agents in elective colonic surgery. A controlled trial. Lancet (1975) 2.72

Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci (1989) 2.23

Long term cimetidine in the management of severe duodenal ulcer dyspepsia. Gastroenterology (1978) 2.15

Proteins containing reductively aminated disaccharides. Synthesis and chemical characterization. Arch Biochem Biophys (1977) 2.09

High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function. Eur J Immunol (2001) 1.99

The major mycolic acids of Mycobacterium smegmatis. Characterization of their homologous series. J Biol Chem (1979) 1.92

Retroperitoneal necrotizing fasciitis. Br J Surg (1992) 1.90

Adult intussusception in Glasgow. Br J Surg (1968) 1.88

Endoscopic sphincterotomy for bile duct stones in patients with intact gallbladders. Br J Surg (1989) 1.73

Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin. Gut (1983) 1.71

The long term stability of the insulin test. Gastroenterology (1970) 1.69

An experience of ulcerative colitis. I. Toxic dilation in 55 cases. Gastroenterology (1969) 1.68

Mycolic acids. A reinvestigation. J Biol Chem (1978) 1.67

Parietal cell hyperplasia induced by the administration of pentagastrin (ICI 50,123) to rats. Gastroenterology (1969) 1.65

Chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. Brain (1983) 1.50

Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic. Sex Transm Infect (2002) 1.49

Epidemiological aspects of Crohn's disease in Clydesdale 1961-1970. Gut (1975) 1.49

Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med (1999) 1.47

Structures of the two homologous series of dialkene mycolic acids from Mycobacterium smegmatis. J Biol Chem (1982) 1.47

Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum. Immunity (1999) 1.45

Randomized evaluation of the single-use SoftSeal and the re-useable LMA Classic laryngeal mask. Anaesth Intensive Care (2004) 1.45

Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin. Anaesth Intensive Care (1999) 1.39

Experience with the multiple-choice paper in the Primary Fellowship Examination in Glasgow: phase IV of an educational study. Br J Med Educ (1973) 1.39

Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase. Lancet (1973) 1.38

Isolation and characterization of a polysaccharide containing 3-O-methyl-D-mannose from Mycobacterium phlei. J Biol Chem (1971) 1.37

Intrarectal metronidazole in the prevention of anaerobic infections after emergency appendicectomy: a controlled clinical trial. Br J Surg (1979) 1.35

Comparison of gastric body and antral pH: a 24 hour ambulatory study in healthy volunteers. Gut (1989) 1.33

Structures of the homologous series of monoalkene mycolic acids from Mycobacterium smegmatis. J Biol Chem (1979) 1.30

Spinal somatosensory evoked potentials in hereditary spastic paraplegia. J Neurol Neurosurg Psychiatry (1981) 1.26

Computer interrogation of patients. Br Med J (1976) 1.25

How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection? Immunol Lett (2001) 1.24

Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist. Gut (1989) 1.23

Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects. Virology (2001) 1.23

Effect of bile salts on antral gastrin release. Gastroenterology (1971) 1.22

Candidacidal activity of myeloperoxidase: mechanisms of inhibitory influence of soluble cell wall mannan. Infect Immun (1983) 1.20

Biliary leakage and peritonitis following removal of T tubes after bile duct exploration. Br J Surg (1989) 1.19

Lectin purification on affinity columns containing reductively aminated disaccharides. J Biol Chem (1977) 1.19

Specific and nonspecific immune factors in dental plaque fluid and saliva from young and old populations. Infect Immun (1981) 1.17

Influence of yeast mannan on human neutrophil functions: inhibition of release of myeloperoxidase related to carbohydrate-binding property of the enzyme. Infect Immun (1981) 1.16

Analysis of basal acid secretion and its relation to the insulin response in normal and duodenal ulcer subjects. New criterion for the insulin test. Gastroenterology (1972) 1.16

Antibodies to carbohydrates: preparation of antigens by coupling carbohydrates to proteins by reductive amination with cyanoborohydride. Methods Enzymol (1978) 1.15

High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections. J Infect Dis (2000) 1.14

The effect on dipyridamole on platelet aggregation and adhesiveness. Scott Med J (1968) 1.14

Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro. J Immunol (1990) 1.13

Studies in the rates of epithelial cell exfoliation from the gastric mucosa in normal and in ulcer subjects. Gut (1971) 1.12

Current concepts of the antibody response: heterogeneity of lymphoid cells, interactions, and factors. Cold Spring Harb Symp Quant Biol (1977) 1.11

Processing of Bacillus subtilis peptidoglycan by a mouse macrophage cell line. Infect Immun (1984) 1.11

Results of surgery for Crohn's disease in the Glasgow region, 1961-70. Br J Surg (1975) 1.10

Time of conversion of insulin response after vagotomy. Gastroenterology (1972) 1.10

Structural and immunochemical characterization of the acidic arabinomannan of Mycobacterium smegmatis. Carbohydr Res (1979) 1.09

The half life (T and one-half) of synthetic human gastrin I in man. Br J Surg (1970) 1.08

Early endoscopic sphincterotomy for retained bile duct stones after gallbladder surgery. Ann R Coll Surg Engl (1991) 1.08

Orthostatic hypotension in bronchial carcinoma. Br Med J (1972) 1.07

Electrodes for 24 hours pH monitoring--a comparative study. Gut (1987) 1.06

In vitro dentinal penetration by tracers used in microleakage studies. Int Endod J (1998) 1.04

The direct coupling of oligosaccharides to proteins and derivatized gels. Arch Biochem Biophys (1974) 1.04

Studies on the substrates of D-fructose 1,6-diphosphate aldolase in solution. Biochemistry (1970) 1.03

Five-year study of cimetidine or surgery for severe duodenal ulcer dyspepsia. Lancet (1982) 1.03

Importance of spin-orbit interaction for the electron spin relaxation in organic semiconductors. Phys Rev Lett (2013) 1.02

Peripheral gangrene as the presentation of myeloproliferative disorders. Br J Surg (1973) 1.01

Methylated polysaccharide activators of fatty acid synthase from Mycobacterium phlei. Methods Enzymol (1975) 0.99

Genetic control of sensitivity to Moloney leukemia virus in mice. IV. Phenotypic heterogeneity of the leukemic mice. J Immunol (1980) 0.98

Effect of cimetidine on prognosis after simple closure of perforated duodenal ulcer. Br J Surg (1987) 0.97

Temperature/light dependent development of selective resistance to photoinhibition of photosystem I. FEBS Lett (1998) 0.97

Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells. J Virol (2000) 0.97

Effects of a specific gastrin antagonist on gastric acid secretion in pouch dogs. Lancet (1967) 0.96

Hepatocellular and gastric carcinoma associated with familial polyposis coli. J Surg Oncol (1988) 0.96

Prevalence of Streptococcus mutans serotypes, Actinomyces, and other bacteria in the plaque of children. J Dent Res (1980) 0.96

"Ulcer--like dyspepsia". Scand J Gastroenterol Suppl (1982) 0.95

Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53. Eur J Immunol (2001) 0.95

The effect of vagotomy on the lower part of the acid dose-response curve to pentagastrin in man. Clin Sci (1972) 0.95

Taking a calculated risk: predictive scoring systems in dyspepsia. Scand J Gastroenterol Suppl (1987) 0.95

A fluid filtration and clearing technique to assess microleakage associated with three dentine bonding systems. J Dent (1999) 0.93

Hyperplasia of the gastric mucosa produced by duodenal obstruction. Gastroenterology (1969) 0.93

The 3'-untranslated sequence of human skeletal muscle alpha-actin mRNA. J Muscle Res Cell Motil (1984) 0.93

Effect of hypophysectomy on the gastric mucosa of the rat. Gut (1968) 0.93

Isolation and characterization of the cell-surface polysaccharides of Porphyromonas gingivalis ATCC 53978. Oral Microbiol Immunol (2000) 0.93

Quality control of radioimmunoassays for proteins: the first two and a half years of a national scheme for serum growth hormone measurements. Ann Clin Biochem (1979) 0.92

Long-term treatment with cimetidine in duodenal ulceration. Lancet (1977) 0.92

Thalassemic hydrops fetalis in two Chinese-Canadian families. Can Med Assoc J (1972) 0.92

The long-term stability of the insulin response after vagotomy. Br J Surg (1969) 0.92

Protamine sulphate hypersensitivity. Anaesth Intensive Care (1981) 0.92

13C nuclear magnetic resonance spectra and the tautomeric equilibria of ketohexoses in solution. Biochemistry (1974) 0.91

The KBG syndrome. Clin Dysmorphol (2000) 0.91

The compatibility of temporary soft materials with immersion denture cleansers. Int J Prosthodont (1990) 0.91